76 active trials 44 recruiting 14 Phase 3 17 disease areas 6 changes in 30 days
4 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 3 with minor changes only.
Primary and study completion pushed from Aug 31, 2025 to Dec 31, 2028
The Netherlands Cancer InstitutePhase 2 NCT04017455 Registry history of NCT04017455 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Also in this update: Primary completion date changed from estimate of Apr 2027 to Sep 4, 2026
The Netherlands Cancer InstituteNot applicable NCT06284304 Registry history of NCT06284304 on ClinicalTrials.gov (opens the registry)
Updated
Interventions modified
The Netherlands Cancer InstitutePhase 2 NCT03026140 Registry history of NCT03026140 on ClinicalTrials.gov (opens the registry)
Updated
Completion pushed from May 1, 2031 to May 1, 2036
The Netherlands Cancer InstituteNot applicable NCT04425967 Registry history of NCT04425967 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 1 | 3 | |
| Phase 1/2 | 4 | |
| Phase 2 | 27 | |
| Phase 2/3 | 4 | |
| Phase 3 | 10 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06875258 | PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for… | Erectile Dysfunction Following Radical Prostatectomy | Recruiting | 2025-03-13 |
| Phase 3 | ||||
| NCT06888817 | Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic… | Radiation Necrosis | Recruiting | 2026-07-13 |
| NCT07281508 | Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial | Cisplatin-related Hearing Loss | Recruiting | 2025-12-15 |
| NCT06857773 | Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined… | Colorectal Neoplasms | Recruiting | 2025-03-04 |
| NCT02810743 | Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer | Breast Cancer | Active, Not Recruiting | 2026-06-01 |
| NCT03772028 | Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy… | Ovarian Cancer | Active, Not Recruiting | 2026-04-08 |
| NCT07486687 | Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With… | Triple Negative Breast Cancer (TNBC), Early Setting | Not Yet Recruiting | 2026-03-20 |
| NCT03348150 | Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal… | Stomach Neoplasm | Active, Not Recruiting | 2025-07-17 |
| NCT01996267 | Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2 | Breast Cancer | Active, Not Recruiting | 2024-03-29 |
| NCT04949113 | Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic… | Malignant Melanoma Stage III | Active, Not Recruiting | 2024-03-08 |
| NCT01646034 | High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast… | Breast Cancer | Active, Not Recruiting | 2022-10-12 |
| Phase 2/3 | ||||
| NCT06279130 | Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel… | Resectable MMR-deficient Solid Tumors | Recruiting | 2026-03-05 |
| NCT07310758 | Contrast-enhanced Ultrasound for Sentinel Node Detection | Melanoma | Recruiting | 2025-12-30 |
| NCT06855095 | Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting… | Neuroendocrine Tumors | Recruiting | 2025-03-03 |
| NCT01057069 | Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer | Breast Cancer | Active, Not Recruiting | 2022-10-12 |
| Phase 2 | ||||
| NCT03026140 | Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon… | Colon Carcinoma | Recruiting | 2026-09-30 |
| NCT05301881 | COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in… | Breast Cancer Invasive | Recruiting | 2026-09-11 |
| NCT06222489 | Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT | Non-Small Cell Lung Carcinoma | Recruiting | 2026-08-10 |
| NCT06353906 | Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer | Urologic Neoplasms | Recruiting | 2025-12-08 |
| NCT05982678 | Basket Study for Oligo-metastatic Breast Cancer | HER2-positive Breast Cancer | Recruiting | 2025-11-26 |
| NCT06823479 | Towards Cure Via Only Ultra-short ICB in CSCC | Cutaneous Squamous Cell Carcinoma (CSCC) | Recruiting | 2025-05-29 |
| NCT06342037 | NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC)… | Metastatic Breast Cancer | Recruiting | 2024-09-19 |
| NCT03815890 | Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO | Breast Cancer | Recruiting | 2024-05-30 |
| NCT05905315 | Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment… | Locally Advanced Vulvar Carcinoma | Recruiting | 2024-04-15 |
| NCT02925234 | The Drug Rediscovery Protocol (DRUP Trial) | Cancer | Recruiting | 2024-01-24 |
Breast Cancer (22) · Colorectal Cancer (7) · Lung Cancer (7) · Non-Small Cell Lung Cancer (NSCLC) (7) · Melanoma (5) · Prostate Cancer (5) · Bladder Cancer (4) · Head & Neck Cancer (4) · Gastric Cancer (3) · HER2-Positive Cancer (3)